Search
Antithrombin III human
go.drugbank.com/drugs/DB11598ApprovedInvestigationalA plasma alpha 2 glycoprotein that accounts for the major antithrombin activity of normal plasma and also inhibits several other enzymes. It is a member of the serpin superfamily.
Products: . - Pulver und Lösungsmittel zur Herstellung einer Injektions- oder Infusionslösung, Pulver und Lösungsmittel zur Herstellung einer Injektions- oder InfusionslösungTeicoplanin
go.drugbank.com/drugs/DB06149ApprovedInvestigationalWithdrawnTeicoplanin is a glycopeptide antibiotic consisting of a mixture of several compounds, five major (named teicoplanin A2-1 through A2-5) and four minor (named teicoplanin RS-1 through RS-4). All teicoplanins share a same glycopeptide core...
Products: Teicoplanin Mylan 100 mg Pulver zur Herstellung einer Injektions-/Infusionslösung oder einer Lösung zum Einnehmen, Teicoplanin Mylan 200 mg Pulver zur Herstellung einer Injektions-/Infusionslösung oder einer Lösung zum EinnehmenTrospium
go.drugbank.com/drugs/DB00209ApprovedInvestigational[L6208] An overactive bladder leads to an increased urge to urinate, frequent urination, and sometimes, loss of control over urination. … [L6208] Trospium is manufactured by _Indevus Pharmaceutical Inc._ and was granted FDA approval in 2007.[L6211]
Products: Trospium Chloride ER, SPASMED 15MG FTAMitomycin
go.drugbank.com/drugs/DB00305ApprovedInvestigationalMitomycin is an antineoplastic antibiotic first isolated by Japanese microbiologists in the 1950s from cultures of Streptomyces caespitosus. It is an alkylating agent that inhibits DNA synthesis (and, at higher concentrations, RNA and pr...
Products: Mitomycin Accord 10 mg Pulver zur Herstellung einer Injektions- / Infusionslösung oder Lösung zur intravesikalen Anwendung, Mitomycin Accord 2 mg Pulver zur Herstellung einer Injektions- / Infusionslösung oder Lösung zur intravesikalen AnwendungFebuxostat
go.drugbank.com/drugs/DB04854ApprovedInvestigational[A230548] In the following year, the FDA for approved febuxostat for use in the chronic management of hyperuricemia in adult patients with gout who have an inadequate response or intolerance to [allopurinol … The manufacturer and the FDA advise health professionals to limit the use of febuxostat to second-line therapy in patients who have inadequate response or intolerance to allopurinol, and to avoid the use
Products: FEBUXOSTAT EG, FEBUXOSTAT HEU 80MG NETNicorandil
go.drugbank.com/drugs/DB09220ApprovedInvestigationalWithdrawnIt is not an approved drug by FDA. It is a niacinamide derivative that induces vasodilation of arterioles and large coronary arteries by activating potassium channels.
Products: NICORANDIL HELMGrain mill dust
go.drugbank.com/drugs/DB10869ApprovedGrain mill dust allergenic extract is used in allergenic testing.
Synonyms: Grain mill dustProducts: Grain Mill DustPancrelipase
go.drugbank.com/drugs/DB00085ApprovedInvestigational[L2509] The pancrelipase mixture was developed by Ortho-McNeil-Janssen Pharmaceuticals, Inc and FDA approved on April 12, 2010.
International brands: Ku-ZymeProducts: KREON 20000PH EU LI EI HKM, KREON 35000 PH EUR LIP EIAmbrisentan
go.drugbank.com/drugs/DB06403ApprovedInvestigationalAmbrisentan is an orally active selective type A endothelin receptor antagonist indicated for the treatment of pulmonary arterial hypertension. It is approved in Europe, Canada and the United States for use as a single agent to improve e...
Products: AMBRISENTAN AL 5MG FTA, AMBRISENTAN AL 10MG FTAFerric derisomaltose
go.drugbank.com/drugs/DB15617ApprovedInvestigationalFerric derisomaltose was developed by Pharmacosmos Therapeutics ad was granted FDA approval in January 2020.
Products: Monofer 100 mg/ml Injektions- oder Infusionslösung